Interactive Investor
>>

Timber Pharmaceuticals Inc Ordinary Shares (AMEX:TMBR) Share Price

TMBR

Timber Pharmaceuticals Inc Ordinary Shares

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XASE

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and scleroderma. The company's development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A Receptor Antagonist).

AMEX:TMBR

US8870801094

USD

Loading...

Loading Comparison

Latest TMBR News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News